Viemed Healthcare (VMD) Competitors $7.98 -0.04 (-0.50%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends VMD vs. CDNA, PNTG, AVAH, AGL, CSTL, GRAL, FLGT, INNV, AUNA, and CELCShould you be buying Viemed Healthcare stock or one of its competitors? The main competitors of Viemed Healthcare include CareDx (CDNA), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), agilon health (AGL), Castle Biosciences (CSTL), Grail (GRAL), Fulgent Genetics (FLGT), InnovAge (INNV), Auna (AUNA), and Celcuity (CELC). These companies are all part of the "healthcare" industry. Viemed Healthcare vs. CareDx The Pennant Group Aveanna Healthcare agilon health Castle Biosciences Grail Fulgent Genetics InnovAge Auna Celcuity CareDx (NASDAQ:CDNA) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership, community ranking and dividends. Which has more risk and volatility, CDNA or VMD? CareDx has a beta of 1.84, indicating that its share price is 84% more volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Is CDNA or VMD more profitable? Viemed Healthcare has a net margin of 4.87% compared to CareDx's net margin of -45.90%. Viemed Healthcare's return on equity of 8.72% beat CareDx's return on equity.Company Net Margins Return on Equity Return on Assets CareDx-45.90% -53.70% -30.42% Viemed Healthcare 4.87%8.72%6.48% Do institutionals and insiders hold more shares of CDNA or VMD? 74.2% of Viemed Healthcare shares are held by institutional investors. 4.9% of CareDx shares are held by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community prefer CDNA or VMD? CareDx received 437 more outperform votes than Viemed Healthcare when rated by MarketBeat users. Likewise, 66.17% of users gave CareDx an outperform vote while only 42.86% of users gave Viemed Healthcare an outperform vote. CompanyUnderperformOutperformCareDxOutperform Votes44066.17% Underperform Votes22533.83% Viemed HealthcareOutperform Votes342.86% Underperform Votes457.14% Which has stronger earnings & valuation, CDNA or VMD? Viemed Healthcare has lower revenue, but higher earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCareDx$312.78M3.53-$190.28M-$2.70-7.63Viemed Healthcare$214.30M1.45$10.24M$0.2729.56 Does the media refer more to CDNA or VMD? In the previous week, CareDx had 9 more articles in the media than Viemed Healthcare. MarketBeat recorded 9 mentions for CareDx and 0 mentions for Viemed Healthcare. CareDx's average media sentiment score of 1.05 beat Viemed Healthcare's score of -0.55 indicating that CareDx is being referred to more favorably in the media. Company Overall Sentiment CareDx Positive Viemed Healthcare Negative Do analysts rate CDNA or VMD? CareDx currently has a consensus price target of $29.60, indicating a potential upside of 43.62%. Given CareDx's higher probable upside, analysts clearly believe CareDx is more favorable than Viemed Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareDx 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43Viemed Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 SummaryViemed Healthcare beats CareDx on 10 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Viemed Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VMD vs. The Competition Export to ExcelMetricViemed Healthcarehealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$310.72M$1.91B$5.13B$9.07BDividend YieldN/A7.04%5.08%4.23%P/E Ratio29.5615.5789.5817.17Price / Sales1.453.171,116.12116.95Price / Cash10.489.7742.8237.86Price / Book2.703.044.774.78Net Income$10.24M$69.56M$120.15M$225.60M7 Day Performance-8.70%-1.73%-1.92%-1.23%1 Month Performance-8.33%-2.76%11.47%3.36%1 Year Performance1.27%-25.02%30.54%16.60% Viemed Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VMDViemed Healthcare1.7209 of 5 stars$7.98-0.5%N/A+3.6%$310.72M$214.30M29.56630Positive NewsHigh Trading VolumeCDNACareDx3.5915 of 5 stars$22.54-1.4%$29.60+31.3%+90.5%$1.21B$280.32M-8.35740PNTGThe Pennant Group4.5689 of 5 stars$29.73+2.1%$38.25+28.7%+100.7%$1.02B$544.89M42.815,791Analyst ForecastNews CoverageAVAHAveanna Healthcare0.9169 of 5 stars$4.99-0.8%$4.27-14.5%+82.5%$964.19M$1.98B-14.7933,500Positive NewsAGLagilon health2.3096 of 5 stars$2.21-1.3%$4.28+93.8%-84.0%$910.56M$5.59B-2.381,117Gap DownCSTLCastle Biosciences2.7304 of 5 stars$28.71-0.6%$39.71+38.3%+34.4%$804.08M$311.88M144.35540Insider TradeGRALGrail0.4714 of 5 stars$23.38+5.5%$16.00-31.6%N/A$785.59M$117.67M0.001,360Gap DownFLGTFulgent Genetics3.7083 of 5 stars$19.71+0.7%$22.00+11.6%-35.9%$602.87M$277.76M-3.551,184News CoveragePositive NewsINNVInnovAge1.2858 of 5 stars$4.45+0.2%$6.50+46.1%-25.4%$602.78M$786.51M-37.002,350Analyst ForecastNews CoverageAUNAAuna3.2169 of 5 stars$6.69+2.8%$13.40+100.3%N/A$494.51M$4.34B0.0014,958News CoverageCELCCelcuity2.6129 of 5 stars$12.26-2.1%$29.17+137.9%-13.6%$455.21MN/A-4.8040News CoverageHigh Trading Volume Related Companies and Tools Related Companies CDNA Competitors PNTG Competitors AVAH Competitors AGL Competitors CSTL Competitors GRAL Competitors FLGT Competitors INNV Competitors AUNA Competitors CELC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VMD) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viemed Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viemed Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.